90 Participants Needed

KNOW Communication Intervention for Alzheimer's Disease

SW
EL
SL
CO
SP
Overseen BySophie Park
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment KNOW for Alzheimer's disease?

The research suggests that structured communication interventions, like the KNOW treatment, can improve communication in Alzheimer's patients. Studies show that caregiver training programs and structured conversations can enhance communication relevance and reduce misunderstandings, which are key components of the KNOW treatment.12345

How does the KNOW Communication Intervention treatment for Alzheimer's disease differ from other treatments?

The KNOW Communication Intervention is unique because it focuses on improving communication between Alzheimer's patients and their caregivers through specific strategies, rather than using medication. This approach aims to reduce stress and improve interactions by training caregivers in effective communication techniques.13678

Research Team

SC

Sara Czaja, PhD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for people aged 65 or older with mild to moderate memory impairment due to conditions like Dementia or Alzheimer's. They must have a certain level of cognitive function, be able to appoint someone for healthcare decisions, and have an informal caregiver. It's not for those under 18, non-English speakers, severely ill individuals, those with major psychiatric disorders, active cancer treatment patients, or those who've already completed advance directives.

Inclusion Criteria

Patient: Montreal Cognitive Assessment (MoCA) score of ≥11-21
Patient: Identification of an informal CP
Care Partner: The person whom the patient indicates provides their informal (unpaid) care
See 5 more

Exclusion Criteria

I have significant issues with my senses, speech, or movement.
I am too sick or weak to participate in interviews.
I am in the late stage of dementia, bed-bound, or expect to be admitted to a nursing home soon.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Development

Development of the communication-based intervention called KNow the Optimal Way (KNOW) for Alzheimer's Disease and Related Dementias (ADRD) patients and care partners

Not specified

Intervention Evaluation

Evaluation of the feasibility and acceptability of the intervention, and testing its preliminary efficacy on various outcomes

3 months
Baseline, Post-Intervention (within 2 weeks), 3-month follow-up

Follow-up

Participants are monitored for changes in engagement in advance care planning, psychological distress, and communication quality

3 months
3-month follow-up

Treatment Details

Interventions

  • KNOW
Trial OverviewThe KNOW intervention is being tested in this study. It aims to improve communication about end-of-life care between patients experiencing memory changes due to dementia-related diseases and their caregivers. The goal is better understanding of the disease progression and more engagement in planning future medical care.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: KNOW InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

A study involving 16 spouses caring for partners with mild Alzheimer's disease revealed that while caregivers recognized some decline in language skills, they lacked knowledge about effective communication strategies.
Despite facing numerous communication challenges, caregivers reported minimal difficulty in communication, highlighting a gap in their understanding that could lead to misunderstandings and frustration in caregiving situations.
What spouse caregivers know about communication in Alzheimer's disease: development of the AD Communication Knowledge Test.Williams, CL.[2022]
In a study involving 55 nursing home residents with Alzheimer's disease, those who participated in conversation-only interventions showed significantly better communication outcomes compared to those who engaged in exercise or a combination of both, particularly in producing nonredundant information and being concise.
The intervention consisted of structured one-on-one conversations held three times a week for 30 minutes over 16 weeks, suggesting that active engagement in conversation can enhance the relevance and effectiveness of communication for individuals with Alzheimer's.
Conversation Intervention with Alzheimer's Patients: Increasing the Relevance of Communication.Tappen, RM., Williams, CL., Barry, C., et al.[2022]
A caregiver training program using the FOCUSED acronym (Face-to-face, Orientation, Continuity, Unsticking, Structure, Exchanges, and Direct) effectively improved caregivers' attitudes and knowledge about Alzheimer’s disease and communication strategies.
The program demonstrated significant positive changes in caregivers' communication interactions with Alzheimer’s patients, addressing one of the major stressors reported by caregivers.
Functional communication with AD patients: a caregiver training program.Ripich, DN.[2004]

References

What spouse caregivers know about communication in Alzheimer's disease: development of the AD Communication Knowledge Test. [2022]
Conversation Intervention with Alzheimer's Patients: Increasing the Relevance of Communication. [2022]
Functional communication with AD patients: a caregiver training program. [2004]
AAC to support conversation in persons with moderate Alzheimer's disease. [2021]
Evaluation of AID-COM, a communication-focused program for family carers of people with early-stage Alzheimer's disease: A pilot study (innovative practice). [2021]
Promoting the maintenance of satisfactory communication: strategies used by caregivers and medical staff with people suffering from Alzheimer's disease. [2018]
Effects of four years of exercise, language, and social interventions on Alzheimer discourse. [2022]
Communication treatment for adults with dementia. [2019]